JLE

Annales de Biologie Clinique

MENU

Immunotherapy-induced hypothyroidism A report of melanoma treated by ipilimumab and nivolumab Volume 76, issue 3, Mai-Juin 2018

Figures


  • Figure 1
Authors
1 Department of endocrinology, University Hospital Bordeaux, France
2 Department of dermatology, University Hospital Bordeaux, France
3 Department of nuclear medicine, University Hospital Bordeaux, France
4 Department of pharmacology, University Hospital Bordeaux, France
5 Groupe de biologie spécialisée, Société française de médecine nucléaire, Paris, France
a Participation équivalente au travail

We report the case of a patient treated by ipilimumab and nivolumab for a metastatic melanoma. After a mild clinical thyroiditis and a transient biological hyperthyroidism she rapidly demonstrated a peripheral hypothyroidism with appearance of antibodies against thyroperoxidase and thyroglobulin.